265 related articles for article (PubMed ID: 11244506)
1. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of the BRCA1 : estrogen receptor interaction.
Ma YX; Tomita Y; Fan S; Wu K; Tong Y; Zhao Z; Song LN; Goldberg ID; Rosen EM
Oncogene; 2005 Mar; 24(11):1831-46. PubMed ID: 15674350
[TBL] [Abstract][Full Text] [Related]
4. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
[TBL] [Abstract][Full Text] [Related]
5. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines.
Fan S; Meng Q; Gao B; Grossman J; Yadegari M; Goldberg ID; Rosen EM
Cancer Res; 2000 Oct; 60(20):5635-9. PubMed ID: 11059753
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
7. p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Cancer Res; 2002 Jan; 62(1):141-51. PubMed ID: 11782371
[TBL] [Abstract][Full Text] [Related]
8. Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity.
Krum SA; Womack JE; Lane TF
Oncogene; 2003 Sep; 22(38):6032-44. PubMed ID: 12955082
[TBL] [Abstract][Full Text] [Related]
9. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
Zhao H; Hart LL; Keller U; Holth LT; Davie JR
J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
[TBL] [Abstract][Full Text] [Related]
10. The functional interaction between HMGA1 and the estrogen receptor requires either the N- or the C-terminal domain of the receptor.
Massaad-Massade L; Tacine R; Dulauroy S; Reeves R; Barouki R
FEBS Lett; 2004 Feb; 559(1-3):89-95. PubMed ID: 14960313
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
14. Identification of BAF57 mutations in human breast cancer cell lines.
Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 expression is not directly responsive to estrogen.
Marks JR; Huper G; Vaughn JP; Davis PL; Norris J; McDonnell DP; Wiseman RW; Futreal PA; Iglehart JD
Oncogene; 1997 Jan; 14(1):115-21. PubMed ID: 9010238
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional suppression of the estrogen receptor by truncated estrogen receptor-alpha.
Ikeda M; Okai M; Miyoshi T; Tone S; Minatogawa Y
Horm Metab Res; 2002 Aug; 34(8):425-30. PubMed ID: 12198596
[TBL] [Abstract][Full Text] [Related]
17. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.
Park JJ; Irvine RA; Buchanan G; Koh SS; Park JM; Tilley WD; Stallcup MR; Press MF; Coetzee GA
Cancer Res; 2000 Nov; 60(21):5946-9. PubMed ID: 11085509
[TBL] [Abstract][Full Text] [Related]
19. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
